Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...
Immunotherapy has revolutionized cancer treatment, yet response rates remain highly variable across tumor types and individual patients. Increasing evidence ...
In this GEN Learning Lab, our expert panelists Linda Orzolek, MS, MB, Xuhuai Ji, MD, PhD, and Christina Chang, PhD, will discuss the current landscape of imaging- and next-generation sequencing-based ...
The origin of many diseases begins at the cellular level and involves multiple molecular interactions. However, previous methods have struggled to accurately observe changes in individual cells.
Explore how clinical multi-omics integration drives systems medicine, detailing data fusion methodologies and lab ...
Explore the serious implications of liver congestion and its connections to fibrosis, cirrhosis, and liver cancer in recent ...
Understand the significance of proteo-transcriptomics in identifying vulnerabilities in Candida auris and addressing drug resistance.
The country’s first end-to-end workflow unites IRB Barcelona’s core facilities to support spatial omics for researchers, ...
In this piece, I highlight one particular talk that caught my interest — given by Elana Fertig, Dean E. Albert Reece Endowed ...
With an incredibly simple workflow, TruPath Genome eliminates traditional library prep. In just 10-15 minutes of hands-on ...
TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data ...
The human lymphatic system is notoriously difficult to map due to its size and variability among individuals. Spatial ...